Ixensor Co (6734.TWO) Stock Price

Ixensor Co Price

CLOSED
5.27
​
Market closed

Revenue has compounded at 68.1% per year over the past 9 years to 26.88 M TWD. Ixensor Co's net margin stands at -174.7%, up from -294.7% several years earlier.

Ixensor Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co business model & stock analysis

iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring.

Frequently asked questions about Ixensor Co

Converted at the current exchange rate, the Ixensor Co share trades at 0.14 EUR (5.27 TWD).

The revenue cannot currently be calculated for Ixensor Co.

The profit cannot currently be calculated for Ixensor Co.

The P/E ratio cannot be calculated for Ixensor Co at the moment.

The P/S cannot be calculated for Ixensor Co currently.

The Eulerpool Quality Score for Ixensor Co is 3/10.

The ISIN of Ixensor Co is TW0006734007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ixensor Co is 6734.TWO. The ticker symbol is used to trade Ixensor Co shares on the stock exchange.

Fair ValueTerminal
5.32 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ixensor.com
Country
Taiwan
Currency
TWD
Initial public offering
Jun 28, 2019
ISIN
TW0006734007
Cusip
Y4R12R102
Market capitalization
214.07 M TWDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
9.27
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-141.61 %
Last updated Nov 5, 2026, 1:31 AM

Ixensor Co Peer Group

Ixensor Co FIGI

6734:TT (Taipei Stock Exchange) · BBG00PGWR3L7

All fundamentals and in-depth analysis of Ixensor Co

Our stock analysis for Ixensor Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ixensor Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.